Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;104:2018-2023
doi: 10.1161/hc4201.097940
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Denollet, J.
Right arrow Articles by Brutsaert, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Denollet, J.
Right arrow Articles by Brutsaert, D. L.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Stress
Related Collections
Right arrow Behavioral/psychosocial - treatment
Right arrow Exercise/exercise testing/rehabilitation

(Circulation. 2001;104:2018.)
© 2001 American Heart Association, Inc.


Clinical Investigation and Reports

Reducing Emotional Distress Improves Prognosis in Coronary Heart Disease

9-Year Mortality in a Clinical Trial of Rehabilitation

Johan Denollet, PhD; Dirk L. Brutsaert, MD

From the Department of Clinical Health Psychology, Tilburg University, the Netherlands (J.D.), and the Center for Cardiac Rehabilitation, University Hospital of Antwerp, Belgium (J.D., D.L.B.).

Correspondence to Johan Denollet, PhD, Clinical Health Psychology, Room P508, Tilburg University, Warandelaan, 2, PO Box 90153, 5000 LE Tilburg, the Netherlands. E-mail j.denollet{at}kub.nl

Background— The impact of treating emotional distress on prognosis in coronary heart disease (CHD) has not been documented convincingly. We tested the hypothesis that treatment-related changes in emotional distress may explain the beneficial effect of rehabilitation on prognosis.

Methods and Results— In this nonrandomized clinical trial, 150 men with CHD participated in rehabilitation (n=78) or received standard medical care (n=72). There were no differences between rehabilitation and control patients with regard to left ventricular ejection fraction (LVEF) or standard care. End points were reduction in distress after 3 months and mortality after 9 years. At the end of the 3-month trial, 64 patients (43%) reported improvement and 22 (15%) reported deterioration in negative affect. Rehabilitation patients improved more (P=0.004) and deteriorated less (P=0.001) than control patients; rehabilitation was effective in reducing distress. After 9 years of follow-up, 15 patients had died (13 cardiac and 2 cancer deaths). Mortality was associated with LVEF <=50% (P=0.038) and deterioration in negative affect (P=0.007). Rate of death was 17% (12/72) for control patients versus 4% (3/78) for rehabilitation patients (P=0.009); rehabilitation was effective in reducing mortality. LVEF <=50% (OR 3.2; 95% CI 1.1 to 9.8; P=0.041) and rehabilitation (OR 0.2; 95% CI 0.1 to 0.7; P=0.016) were independent predictors of mortality. Rehabilitation warded off the deleterious effect of deterioration in negative affect on prognosis.

Conclusions— Deterioration in negative affect is associated with a high long-term mortality risk. Warding off deterioration in negative affect is a mechanism that may explain the beneficial effect of comprehensive rehabilitation on prognosis in patients with CHD.


Key Words: myocardial infarction • mortality • stress • depression • trials




This article has been cited by other articles:


Home page
HeartHome page
A Steptoe and G J Molloy
Personality and heart disease
Heart, July 1, 2007; 93(7): 783 - 784.
[Full Text] [PDF]


Home page
Eur Heart JHome page
J. Denollet, S. S. Pedersen, A. T.L. Ong, R. A.M. Erdman, P. W. Serruys, and R. T. van Domburg
Social inhibition modulates the effect of negative emotions on cardiac prognosis following percutaneous coronary intervention in the drug-eluting stent era
Eur. Heart J., January 2, 2006; 27(2): 171 - 177.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S Al-Ruzzeh, T Athanasiou, O Mangoush, J Wray, T Modine, S George, and M Amrani
Predictors of poor mid-term health related quality of life after primary isolated coronary artery bypass grafting surgery
Heart, December 1, 2005; 91(12): 1557 - 1562.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. K. Ferketich and P. F. Binkley
Psychological distress and cardiovascular disease: results from the 2002 National Health Interview Survey
Eur. Heart J., September 2, 2005; 26(18): 1923 - 1929.
[Abstract] [Full Text] [PDF]


Home page
Nurs Sci QHome page
S. Penckofer, C. E. Ferrans, N. Fink, M. L. Barrett, and K. Holm
Quality of Life in Women Following Coronary Artery Bypass Graft Surgery
Nurs Sci Q, April 1, 2005; 18(2): 176 - 183.
[Abstract] [PDF]


Home page
Psychosom. Med.Home page
J. Denollet
DS14: Standard Assessment of Negative Affectivity, Social Inhibition, and Type D Personality
Psychosom Med, January 1, 2005; 67(1): 89 - 97.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. S. Pedersen, P. A. Lemos, P. R. van Vooren, T. K.K. Liu, J. Daemen, R. A.M. Erdman, P. C. Smits, P. W.J.C. Serruys, and R. T. van Domburg
Type D personality predicts death or myocardial infarction after bare metal stent or sirolimus-eluting stent implantation: A rapamycin-eluting stent evaluated at rotterdam cardiology hospital (RESEARCH) registry substudy
J. Am. Coll. Cardiol., September 1, 2004; 44(5): 997 - 1001.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
S. S. Pedersen, R. T. van Domburg, D. A. M. J. Theuns, L. Jordaens, and R. A. M. Erdman
Type D Personality Is Associated With Increased Anxiety and Depressive Symptoms in Patients With an Implantable Cardioverter Defibrillator and Their Partners
Psychosom Med, September 1, 2004; 66(5): 714 - 719.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
N. Schneiderman, P. G. Saab, D. J. Catellier, L. H. Powell, R. F. DeBusk, R. B. Williams, R. M. Carney, J. M. Raczynski, M. J. Cowan, L. F. Berkman, et al.
Psychosocial Treatment Within Sex by Ethnicity Subgroups in the Enhancing Recovery in Coronary Heart Disease Clinical Trial
Psychosom Med, July 1, 2004; 66(4): 475 - 483.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
D. K. Moser and K. Dracup
Role of Spousal Anxiety and Depression in Patients' Psychosocial Recovery After a Cardiac Event
Psychosom Med, July 1, 2004; 66(4): 527 - 532.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S Newman
Engaging patients in managing their cardiovascular health
Heart, June 1, 2004; 90(suppl_4): iv9 - iv13.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. J. M. H. Strik, J. Denollet, R. Lousberg, and A. Honig
Comparing symptoms of depression and anxiety as predictors of cardiac events and increased health care consumption after myocardial infarction
J. Am. Coll. Cardiol., November 19, 2003; 42(10): 1801 - 1807.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S Newman
The psychological perspective: a professional view
Heart, May 1, 2003; 89(90002): ii16 - 18.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Bierhaus, J. Wolf, M. Andrassy, N. Rohleder, P. M. Humpert, D. Petrov, R. Ferstl, M. von Eynatten, T. Wendt, G. Rudofsky, et al.
A mechanism converting psychosocial stress into mononuclear cell activation
PNAS, February 18, 2003; 100(4): 1920 - 1925.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
The Task Force on the Management of Acute Myocardi, F. Van de Werf, D. Ardissino, A. Betriu, D. V. Cokkinos, E. Falk, K. A.A. Fox, D. Julian, M. Lengyel, F.-J. Neumann, et al.
Management of acute myocardial infarction in patients presenting with ST-segment elevation
Eur. Heart J., January 1, 2003; 24(1): 28 - 66.
[Full Text] [PDF]